Metabolic profile in women with polycystic ovary syndrome across adult life
Author
dc.contributor.author
Echiburú López, Bárbara
Author
dc.contributor.author
Crisosto King, Nicolás
Author
dc.contributor.author
Maliqueo Yevilao, Manuel
Author
dc.contributor.author
Pérez Bravo, Francisco
Author
dc.contributor.author
Ladrón de Guevara, Amanda
Author
dc.contributor.author
Hernández, Paola
Author
dc.contributor.author
Cavada Chacón, Gabriel
Author
dc.contributor.author
Rivas, Catalina
Author
dc.contributor.author
Clavel, Andrés
Author
dc.contributor.author
Sir Petermann, Teresa
Admission date
dc.date.accessioned
2016-09-12T15:54:23Z
Available date
dc.date.available
2016-09-12T15:54:23Z
Publication date
dc.date.issued
2016
Cita de ítem
dc.identifier.citation
Metabolism Volume 65, Issue 5, May 2016, Pages 776–782
es_ES
Identifier
dc.identifier.issn
1532-8600
Identifier
dc.identifier.other
10.1016/j.metabol.2016.01.006
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/140368
Abstract
dc.description.abstract
Objective. To assess insulin sensitivity, insulin secretion and metabolic profile in women with polycystic ovary syndrome (PCOS) in different stages of reproductive life.
Materials and methods. In a cross-sectional study, 190 PCOS women (PCOSw) and 99 controls (Cw) aged between 18 and 55 years were included. PCOSw and Cw were distributed into 3 stages of reproductive life: early reproductive age (18-34 years old), late reproductive age (35-40 years old) and perimenopausal period (41-55 years old). Waist circumference (WC), body mass index (BMI) and blood pressure (BP) were recorded. An oral glucose tolerance test (OGTT) with measurement of glucose and insulin was performed. Sex steroids and lipid profile were also determined in the fasting sample. Insulin sensitivity was assessed by HOMA-IR and ISI composite, and insulin secretion by HOMA-beta and insulinogenic index. Visceral adiposity index (VAI) and lipid accumulation product (LAP) were also calculated. Metabolic syndrome (MS) was assessed by the IDF and ATPIII criteria.
Results. At early reproductive age, PCOSw showed higher BMI, WC, and VAI and a higher prevalence of MS compared to Cw (p < 0.05). In addition, at late reproductive age PCOSw also showed elevated total cholesterol, triglycerides, insulin secretion, LAP and BP. At perimenopausal period, these parameters were not different between Cw and PCOSw. Within the PCOSw group, HOMA-beta was lower at late reproductive and perimenopausal periods compared to the early reproductive age. Regarding control women, a deterioration of anthropometric and metabolic parameters was observed in perimenopausal women compared to early and late reproductive women.
Conclusions. Our results suggest that metabolic derangements associated with PCOS are more evident at the early and late reproductive ages. On the other hand, during perimenopause, there is no further deterioration of metabolic parameters. Nevertheless, a disruption in pancreatic 3-cell function is evidenced at this stage.
es_ES
Patrocinador
dc.description.sponsorship
Fondo Nacional de Desarrollo Cientifico y Tecnologico (National Fund for Scientific and Technological Research; Fondecyt) 1,110,864
SOCHED (Chilean Society of Endocrinology and Diabetes) 2009-48 05